Emmprin and KSHV: new partners in viral cancer pathogenesis

Cancer Lett. 2013 Sep 1;337(2):161-6. doi: 10.1016/j.canlet.2013.05.037. Epub 2013 Jun 3.

Abstract

Emmprin (CD147; basigin) is a multifunctional glycoprotein expressed at higher levels by cancer cells and stromal cells in the tumor microenvironment. Through direct effects within tumor cells and promotion of tumor-stroma interactions, emmprin participates in induction of tumor cell invasiveness, angiogenesis, metastasis and chemoresistance. Although its contribution to cancer progression has been widely studied, the role of emmprin in viral oncogenesis still remains largely unclear, and only a small body of available literature implicates emmprin-associated mechanisms in viral pathogenesis and tumorigenesis. We summarize these data in this review, focusing on the role of emmprin in pathogenesis associated with the Kaposi sarcoma-associated herpesvirus (KSHV), a common etiology for cancers arising in the setting of immune suppression. We also discuss future directions for mechanistic studies exploring roles for emmprin in viral cancer pathogenesis.

Keywords: CD147; Emmprin; KSHV; Kaposi sarcoma; Primary effusion lymphoma.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Basigin / metabolism*
  • Cell Movement
  • Cell Transformation, Viral*
  • Disease Progression
  • Drug Resistance, Neoplasm
  • Herpesvirus 8, Human / pathogenicity*
  • Humans
  • Immunocompromised Host
  • Neoplasm Invasiveness
  • Sarcoma, Kaposi / drug therapy
  • Sarcoma, Kaposi / metabolism*
  • Sarcoma, Kaposi / pathology
  • Sarcoma, Kaposi / virology*
  • Signal Transduction

Substances

  • Basigin